181 related articles for article (PubMed ID: 31229458)
1. Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program.
Liao X; Qiu S; Zheng X; Ai J; Jin X; Gong L; Bao Y; Jin K; Li H; Yang L; Wei Q
Clin Genitourin Cancer; 2019 Oct; 17(5):e968-e980. PubMed ID: 31229458
[TBL] [Abstract][Full Text] [Related]
2. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
3. Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software.
Zhuang W; Chen J; Li Y; Liu W
Int Urol Nephrol; 2020 Feb; 52(2):253-262. PubMed ID: 31612422
[TBL] [Abstract][Full Text] [Related]
4. Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinoma.
Raza SJ; Miller C; May A; Davaro F; Siddiqui SA; Hamilton Z
Can J Urol; 2019 Aug; 26(4):9852-9858. PubMed ID: 31469641
[TBL] [Abstract][Full Text] [Related]
5. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
[TBL] [Abstract][Full Text] [Related]
6. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
[TBL] [Abstract][Full Text] [Related]
7. More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer.
Mao W; Huang X; Kong M; Fan J; Geng J
Int Urol Nephrol; 2019 Apr; 51(4):641-654. PubMed ID: 30758771
[TBL] [Abstract][Full Text] [Related]
8. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
[TBL] [Abstract][Full Text] [Related]
9. Lymph node dissection in renal cell carcinoma.
Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and End Result (SEER) database review.
Walker JP; Johnson JS; Eguchi MM; Saltzman AF; Cockburn M; Cost NG
J Pediatr Urol; 2020 Feb; 16(1):81-88. PubMed ID: 31791906
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node density on cancer staging system for gastric cancer without distal metastasis: a population-based analysis of SEER database.
Liu Y; Cui H; Xu X; Liang W
World J Surg Oncol; 2022 Sep; 20(1):325. PubMed ID: 36175896
[TBL] [Abstract][Full Text] [Related]
12. Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.
Kates M; Lavery HJ; Brajtbord J; Samadi D; Palese MA
Ann Surg Oncol; 2012 Aug; 19(8):2693-9. PubMed ID: 22526899
[TBL] [Abstract][Full Text] [Related]
13. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Linares Espinós E; Lorentz A; Martinez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Libertino JA; Evans CP
Urol Oncol; 2018 Feb; 36(2):79.e11-79.e17. PubMed ID: 29129353
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
[TBL] [Abstract][Full Text] [Related]
15. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Prognostic Value of Lymph Node Dissection in Treating Adrenocortical Carcinoma: A National Experience.
Alanee S; Dynda D; Holland B
Anticancer Res; 2015 Oct; 35(10):5575-9. PubMed ID: 26408728
[TBL] [Abstract][Full Text] [Related]
17. Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer.
Srivastava A; Rivera-Núñez Z; Kim S; Sterling J; Farber NJ; Radadia KD; Patel HV; Modi PK; Goyal S; Parikh R; Mayer TM; Saraiya B; Sadimin ET; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Cancer; 2020 Jul; 126(13):2991-3001. PubMed ID: 32329899
[TBL] [Abstract][Full Text] [Related]
18. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns.
Tachibana I; Vasquez R; Mahmoud M; Kern SQ; Patel RS; King J; Adra N; Boris RS; Cary C; Rice KR
Urol Oncol; 2022 Nov; 40(11):495.e11-495.e17. PubMed ID: 36154800
[TBL] [Abstract][Full Text] [Related]
19. The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance, epidemiology, and End Results dataset.
Qian K; Sun W; Guo K; Zheng X; Sun T; Chen L; Xiang J; Li D; Wu Y; Ji Q; Wang Z
Eur J Surg Oncol; 2019 Jun; 45(6):1025-1032. PubMed ID: 30472214
[TBL] [Abstract][Full Text] [Related]
20. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
